Skip to main content
Press release October 26, 2026

Biohaven Oral Presentation at ASN Kidney Week 2026 Spotlights BHV-1420, a Novel TRAP Degrader Designed to Selectively Remove the Autoantibodies that Drive Membranous Nephropathy

Biohaven Ltd. (BHVN)

We couldn't retrieve the full text for this release. Read it on the company's site.

Read full release on company site